Raymond James Upgrades WebMD Health Corp. (WBMD) to Strong Buy
- Wall St slips as dour earnings, chip stocks weigh
- ASML slides as Q1 sales fall short but firm still on track for 2025 revenue target
- United Airlines maintains forecast after Q1 results top Wall Street estimates
- Dollar eases, near 5-1/2 month high, on hawkish Fed outlook
- Abbott Laboratories (ABT) narrows 2024 earnings guidance, shares slip
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- ICZOOM Group (IZM) Discloses Request to Withdraw Registration Statement on Form F-1
- Alaska Airlines flights resume after being grounded over aircraft system issue
- GE HealthCare (GEHC) Announces Resignation of Jan Makela, CEO of Imaging
- Barnes & Noble Education (BNED) Enters Definitive Agreement with Immersion (IMMR)
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
- Midday movers: Morgan Stanley, UnitedHealth rise; Tesla falls
- Morgan Stanley, UnitedHealth and Bank of America rise premarket; Tesla falls
- After-hours movers: Tesla, Gildan Activewear, Macatawa Bank, and more
WebMD (WBMD) Guidance 'Optimistic', Says Analyst
February 22, 2013 10:23 AM ESTWebMD Health Corp. (NASDAQ: WBMD) stock opened higher on Friday after the company reported better than expected Q4 revenue and guidance that was well ahead of the Street. This prompted analysts at Stifel to upgrade WebMD to Buy. Others on Wall Street are not... More
Stifel Nicolaus Upgrades WebMD Health Corp. (WBMD) to Buy
February 22, 2013 8:05 AM ESTStifel Nicolaus upgraded WebMD Health Corp. (NASDAQ: WBMD) from Hold to Buy.
For an analyst ratings summary and ratings history on WebMD Health Corp. click here. For more ratings news on WebMD Health Corp. click here.
Shares of WebMD Health Corp. closed at $16.30 yesterday, with a 52 week range of $13.13-$26.49.... More
WebMD Health Corp. (WBMD) Misses Q4 EPS by 4c
February 21, 2013 4:07 PM ESTWebMD Health Corp. (NASDAQ: WBMD) reported Q4 EPS of ($0.08), $0.04 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $132.7 million versus the consensus estimate of $124.14 million.
WebMD Health Corp. sees FY2013 EPS of $-0.13--0.45, versus the consensus of... More